Selected pharmaceutical pipeline projects Project/ Potential indication/ Planned Current News update Compound Disease area submissions Phase ACZ885 Refractory gout 2010 III - On track for 2010 submission SJIA 2011 III Type 2 diabetes 2012 II - Phase III start targeted for December 2010
2012 III - Essai de phase III NSCLC de première intention cessé en mars 2010, poursuite de l’essai de phase III NSCLC de seconde intention (analyse intermédiaire au S2 2010)
